Rate My Professor Richard McNeill

McNeill has authored or co-authored numerous peer-reviewed publications advancing evidence-based practices in clinical pharmacology and palliative medicine. Notable works include 'Polypharmacy in Palliative Care: Two Deprescribing Tools Compared with a Clinical Review' (2021), 'Drug Metabolism in Severe Chronic Obstructive Pulmonary Disease: A Phenotyping Cocktail Study' (2021), 'Cyclizine Pharmacovigilance in Hospice/Palliative Care: Net Effects for Nausea or Vomiting' (2022), 'Current Pharmacological Strategies for Symptomatic Reduction of Persistent Breathlessness - A Literature Review' (2022), 'Non-Steroidal Anti-Inflammatory Drugs for Pain in Hospice/Palliative Care: An International Pharmacovigilance Study' (2023), 'Optimising Interruptive Clinical Decision Support Alerts for Antithrombotic Duplicate Prescribing in Hospital' (2024), 'Inpatient Management of Gout: Serum Urate Testing and Allopurinol Dose Adjustment' (2025), 'Investigation of a Broad-Spectrum Micronutrient Formulation as a Possible Precipitant of Pharmacokinetic Micronutrient-Drug Interactions' (2025), 'Routine Therapeutic Drug Monitoring of Dabigatran: Experience at a Tertiary Center' (2020), and 'A Randomised Controlled Trial of Patient Information Leaflets as a Medication Counselling Aid' (2019). These contributions draw on real-world data from prospective cohort studies, pharmacovigilance analyses, and pharmacokinetic investigations to enhance medication safety, efficacy, and quality use in vulnerable patient populations.